Vasculitis, atherosclerosis, and altered HDL composition in heme-oxygenase-1-knockout mice

International Journal of Hypertension

Volumn 2012, Issue , 2012, Pages

  Ishikawa, Kazunobu ^a   Navab, Mohamad ^b   Lusis, Aldons J ^b  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL; HEME OXYGENASE 1; HIGH DENSITY LIPOPROTEIN; LIPID HYDROPEROXIDE; LIPOPROTEIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA SINUS; AORTITIS; ARTERITIS; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CARDIOVASCULAR SYSTEM; CELL INFILTRATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME DEFICIENCY; ENZYME REPRESSION; GENOTYPE; HEMATOCRIT; HOMOZYGOSITY; HYPOALPHALIPOPROTEINEMIA; KNOCKOUT MOUSE; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; VASCULITIS;

EID: 84866165298     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2012/948203     Document Type: Article

References (33)

1. Maines M. D., Kappas A., Cobalt induction of hepatic heme oxygenase; with evidence that cytochrome P-450 is not essential for this enzyme activity. Proceedings of the National Academy of Sciences of the United States of America 1974 71 11 4293 4297 2-s2.0-0006476631
2. Maines M. D., Ibrahim N. G., Kappas A., Solubilization and partial purification of heme oxygenase from rat liver. Journal of Biological Chemistry 1977 252 16 5900 5903 2-s2.0-0017760327 (Pubitemid 8180226)
3. Yoshida T., Kikuchi G., Purification and properties of heme oxygenase from pig spleen microsomes. Journal of Biological Chemistry 1978 253 12 4224 4229 2-s2.0-0017850764 (Pubitemid 8380644)
4. Poss K. D., Tonegawa S., Reduced stress defense in heme oxygenase 1-deficient cells. Proceedings of the National Academy of Sciences of the United States of America 1997 94 20 10925 10930 2-s2.0-0030886054 10.1073/pnas.94.20. 10925 (Pubitemid 27430837)
5. Stocker R., Perrella M. A., Heme oxygenase-1: a novel drug target for atherosclerotic diseases? Circulation 2006 114 20 2178 2189 2-s2.0-33750969074 10.1161/CIRCULATIONAHA.105.598698 (Pubitemid 44747899)
6. Stocker R., Yamamoto Y., McDonagh A. F., Glazer A. N., Ames B. N., Bilirubin is an antioxidant of possible physiological importance. Science 1987 235 4792 1043 1046 2-s2.0-0023132858 (Pubitemid 17049750)
7. Kawamura K., Ishikawa K., Wada Y., Kimura S., Matsumoto H., Kohro T., Itabe H., Kodama T., Maruyama Y., Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 1 155 160 2-s2.0-11144238700 10.1161/01.ATV. 0000148405.18071.6a (Pubitemid 40054269)
8. Theil E. C., Regulation of ferritin and transferrin receptor mRNAs. Journal of Biological Chemistry 1990 265 9 4771 4774 2-s2.0-0025248551
9. Balla G., Jacob H. S., Balla J., Rosenberg M., Nath K., Apple F., Eaton J. W., Vercellotti G. M., Ferritin: a cytoprotective antioxidant strategem of endothelium. Journal of Biological Chemistry 1992 267 25 18148 18153 2-s2.0-0026657174
10. Stone J. R., Marletta M. A., Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry 1994 33 18 5636 5640 2-s2.0-0028228808 10.1021/bi00184a036 (Pubitemid 24163003)
11. Ryter S. W., Alam J., Choi A. M. K., Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiological Reviews 2006 86 2 583 650 2-s2.0-33645945014 10.1152/physrev.00011.2005
12. Ishikawa K., Navab M., Leitinger N., Fogelman A. M., Lusis A. J., Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. Journal of Clinical Investigation 1997 100 5 1209 1216 2-s2.0-0030930697 (Pubitemid 27386307)
13. Ishikawa K., Sugawara D., Wang X. P., Suzuki K., Itabe H., Maruyama Y., Lusis A. J., Heme oxygenase-1 inhibits atherosclerotic lesion formation in LDL-receptor knockout mice. Circulation Research 2001 88 5 506 512 2-s2.0-0035896220 (Pubitemid 32240914)
14. Brown M. S., Ho Y. K., Goldstein J. L., The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters. Journal of Biological Chemistry 1980 255 19 9344 9352 2-s2.0-0019162068 (Pubitemid 11202897)
15. Watson A. D., Berliner J. A., Hama S. Y., La Du B. N., Faull K. F., Fogelman A. M., Navab M., Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. Journal of Clinical Investigation 1995 96 6 2882 2891 2-s2.0-0028784851
16. Aviram M., Rosenblat M., Bisgaier C. L., Newton R. S., Primo-Parmo S. L., La Du B. N., Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: a possible peroxidative role for paraoxonase. Journal of Clinical Investigation 1998 101 8 1581 1590 2-s2.0-0032522985 (Pubitemid 28198486)
17. Boisvert W. A., Black A. S., Curtiss L. K., ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of apoE-deficient mice transplanted with apoE-expressing macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 3 525 530 2-s2.0-0032974688 (Pubitemid 29135151)
18. Navab M., Reddy S. T., Van Lenten B. J., Anantharamaiah G. M., Fogelman A. M., The role of dysfunctional HDL in atherosclerosis. Journal of Lipid Research 2009 50 S145 S149 2-s2.0-66349127140 10.1194/jlr.R800036-JLR200
19. Takahashi Y., Chiba H., Matsuno K., Akita H., Hui S. P., Nagasaka H., Nakamura H., Kobayashi K., Tandon N. N., Jamieson G. A., Native lipoproteins inhibit platelet activation induced by oxidized lipoproteins. Biochemical and Biophysical Research Communications 1996 222 2 453 459 2-s2.0-0030585385 10.1006/bbrc.1996.0765 (Pubitemid 26335037)
20. Poss K. D., Tonegawa S., Heme oxygenase 1 is required for mammalian iron reutilization. Proceedings of the National Academy of Sciences of the United States of America 1997 94 20 10919 10924 2-s2.0-0030886381 10.1073/pnas.94.20. 10919 (Pubitemid 27430836)
21. Soares M. P., Lin Y., Anrather J., Csizmadia E., Takigami K., Sato K., Grey S. T., Colvin R. B., Choi A. M., Poss K. D., Bach F. H., Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nature Medicine 1998 4 9 1073 1077 2-s2.0-0031697123 10.1038/2063 (Pubitemid 28417343)
22. Qiao J. H., Xie P. Z., Fishbein M. C., Kreuzer J., Drake T. A., Demer L. L., Lusis A. J., Pathology of atheromatous lesions in inbred and genetically engineered mice: genetic determination of arterial calcification. Arteriosclerosis and Thrombosis 1994 14 9 1480 1497 2-s2.0-0028105909
23. Warden C. H., Hedrick C. C., Qiao J. H., Castellani L. W., Lusis A. J., Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science 1993 261 5120 469 472 2-s2.0-0027279942 (Pubitemid 23276555)
24. Havel R. J., Eder H. A., Bragdon J. H., The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. The Journal of Clinical Investigation 1955 34 9 1345 1353 2-s2.0-33745026603
25. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J., Protein measurement with the Folin phenol reagent. The Journal of Biological Chemistry 1951 193 1 265 275 2-s2.0-71849104860
26. Laemmli U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970 227 5259 680 685 2-s2.0-0014949207 10.1038/227680a0
27. Gan K. N., Smolen A., Eckerson H. W., La Du B. N., Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metabolism and Disposition 1991 19 1 100 106 2-s2.0-0026096803
28. Willis D., Moore A. R., Frederick R., Willoughby D. A., Heme oxygenase: a novel target for the modulation of the inflammatory response. Nature Medicine 1996 2 1 87 90 2-s2.0-0030045835 10.1038/nm0196-87 (Pubitemid 26029572)
29. Rubin E. M., Krauss R. M., Spangler E. A., Verstuyft J. G., Clift S. M., Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A1. Nature 1991 353 6341 265 267 2-s2.0-0025902231 10.1038/353265a0 (Pubitemid 21896769)
30. Artola R. L., Conde C. B., Bagatolli L., Pécora R. P., Fidelio G. D., Kivatinitz S. C., High-density lipoprotein from hypercholesterolemic animals has peroxidized lipids and oligomeric apolipoprotein A-I. Its putative role in atherogenesis. Biochemical and Biophysical Research Communications 1997 239 2 570 574 2-s2.0-0031581103 10.1006/bbrc.1997.7496 (Pubitemid 27489006)
31. Getz G. S., Reardon C. A., Paraoxonase, a cardioprotective enzyme: continuing issues. Current Opinion in Lipidology 2004 15 3 261 267 2-s2.0-2642570389 10.1097/00041433-200406000-00005 (Pubitemid 38716558)
32. Mackness M. I., Arrol S., Durrington P. N., Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Letters 1991 286 1-2 152 154 2-s2.0-0025864611 10.1016/0014-5793(91)80962-3
33. Shih D. M., Gu L., Xia Y. R., Navab M., Li W. F., Hama S., Castellani L. W., Furlong C. E., Costa L. G., Fogelman A. M., Lusis A. J., Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 1998 394 6690 284 287 2-s2.0-0032537833 10.1038/28406 (Pubitemid 28335041)